Margenza Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Margenza General Information
Description
A prescription medicine's global rights for the treatment of cancer. The medicine is for use in combination with chemotherapy for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease.
Contact Information
Website
www.margenza.comCorporate Office
- Rockville, MD
- United States
Corporate Office
- Rockville, MD
- United States
Margenza Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Margenza Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Margenza FAQs
-
Where is Margenza headquartered?
Margenza is headquartered in Rockville, MD.
-
What industry is Margenza in?
Margenza’s primary industry is Buildings and Property.
-
Is Margenza a private or public company?
Margenza is a Private company.
-
What is the current valuation of Margenza?
The current valuation of Margenza is .
-
What is Margenza’s current revenue?
The current revenue for Margenza is .
-
Who are Margenza’s investors?
Macrogenics has invested in Margenza.
-
When was Margenza acquired?
Margenza was acquired on 12-Nov-2024.
-
Who acquired Margenza?
Margenza was acquired by Tersera Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process